Tag: Cancer
BioVoice eMagazine September 2024 | Issue 5 | Volume 5
The Cover Story focuses on India's crucial role in ensuring global vaccine security with an exclusive interview of Dr Krishna Ella, Executive Chairman, Bharat Biotech & President, Indian Vaccine Manufacturers Association. Read interviews of Sriram Natarajan, CEO, Molbio Diagnostics and Dr Renuka Diwan, CEO, BioPrime Agrisolutions. Also features Expert Insights, Special Story and Startup Special.
Transforming Cancer Care: Advances in AI & ML will help in...
With advancements in diagnostics, precision medicine is paving the way for a new era in cancer care, significantly improving patient outcomes, writes Dr Avinash Phadke
Budget 2024: Kiran Mazumdar Shaw welcomes abolishing of angel tax, focus...
Kiran Mazumdar Shaw, Chairperson, Biocon & Biocon Biologics called upon the government to consider GST exemption for all cancer drugs to make cancer care more affordable for patients
Sri Sathya Sai University and TDU join forces to combat cancer...
The partnership Aims to Develop Holistic Health Solutions Through Integrative Nutritional Research Combining Ayurveda and Modern Science
RGCIRC creates history with India’s first-ever telesurgery in cancer care
This groundbreaking procedure, which represents a monumental leap in medical technology, ensures precision and safety while overcoming geographical barriers
RGCIRC emphasizes reintegrating women breast cancer survivors
This initiative brought together plastic and reconstructive surgeons, breast onco-surgeons, oncologists, psychologists and body positivity activists under one roof to ignite hope and empower survivors
World Brain Tumor Day: 20% brain cancer patients in India are...
Various programs and screening camps are organized in India to spread awareness about brain tumour symptoms, prevention and measures
CAR-T cell therapy gives a new lease of life to a...
Following a thorough evaluation, the patient achieved molecular remission post-immunotherapy and was later planned for CAR T-cell therapy
Wider access to clinical trials necessary to democratize precision oncology: Report
While advancements in targeted therapies and biomarker discovery show promise, challenges like tumor complexity and unequal access remain
Sun Pharma to present results of the Phase III PIVOTAL trial...
PIVOTAL is an open label, randomized, multicenter, Phase III trial evaluating Nidlegy as a neoadjuvant intralesional therapy






























































